Axsome Therapeutics, Inc(NASDAQ:AXSM) 
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in t...
Website: http://www.axsome.com
Founded: 2012
Full Time Employees: 53
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 105.34
H 106.10
L 98.80
C 98.86
V 990,467
10EMA 98.86
20EMA 98.86
60EMA 98.86
120EMA 98.86
250EMA 98.86